mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

Juan Manuel Carreño; Gagandeep Singh; Johnstone Tcheou; Komal Srivastava; Charles Gleason; Hiromi Muramatsu; Parnavi Desai; Judith A. Aberg; Rachel L. Miller; PARIS study group; Norbert Pardi; Viviana Simon; Florian Krammer

doi:10.1101/2022.04.15.22273914

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

View ORCID ProfileJuan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu, Parnavi Desai, Judith A. Aberg, Rachel L. Miller, PARIS study group, Norbert Pardi, Viviana Simon, Florian Krammer

doi: https://doi.org/10.1101/2022.04.15.22273914

Juan Manuel Carreño

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Juan Manuel Carreño
For correspondence: florian.krammer@mssm.edu viviana.simon@mssm.edu jm.carreno@mssm.edu

Gagandeep Singh

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johnstone Tcheou

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Komal Srivastava

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charles Gleason

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hiromi Muramatsu

2Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Parnavi Desai

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Judith A. Aberg

3Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rachel L. Miller

4Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Norbert Pardi

2Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Viviana Simon

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Icahn School of Medicine at Mount Sinai, New York, NY, USA

5The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

6Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: florian.krammer@mssm.edu viviana.simon@mssm.edu jm.carreno@mssm.edu

Florian Krammer

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

6Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: florian.krammer@mssm.edu viviana.simon@mssm.edu jm.carreno@mssm.edu

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted April 17, 2022.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

Juan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu, Parnavi Desai, Judith A. Aberg, Rachel L. Miller, PARIS study group, Norbert Pardi, Viviana Simon, Florian Krammer

medRxiv 2022.04.15.22273914; doi: https://doi.org/10.1101/2022.04.15.22273914

Share This Article: